Brain Bank Core

脑库核心

基本信息

  • 批准号:
    10460264
  • 负责人:
  • 金额:
    $ 66.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-30 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

The overarching goals of the Brain Banking Core (BBC) are to conduct and foster research on RHI and TBI and to determine associations with AD, ADRD, CTE, and other neurodegenerative pathology as well as clinical outcomes. The BBC will include 8 brain bank cohorts, 6 from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System: the BU Alzheimer Disease Center (BUADC), Framingham Heart Study (FHS), VA Post-Traumatic Stress Disorder (PTSD), VA amyotrophic lateral sclerosis (ALS), Chronic Effects of Neurotrauma (CENC) and VA-BU-CLF (UNITE) and 2 from the Icahn School of Medicine at Mount Sinai (ISMMS) to systematically evaluate the precise neuropathology of RHI and TBI-related neurodegeneration. These combined brain banks contain over 2500 cases, and include the largest neuropathologically confirmed autopsy cohort of CTE subjects (n= 361) in the world. In addition, the LETBI, CENC, ALS, and UNITE brain banks hold at least 50 cases of remote, moderately-severe TBI with a chronic cavitary lesion (cTBI). The specific aims of the BBC consist of fundamental Core functions, namely to perform state-of-the-art diagnostic neuropathology, optimally store and distribute CNS tissue and other biospecimens, and provide neuropathological data for Projects 1-3 and to the Federal Interagency Traumatic Brain Injury Research (FITBIR) for the general scientific community. All neuropathological protocols will be aligned with those proposed by the NINDS Neuropathological CTE Consensus Conference for biospecimen collection, blocking, staining and storage, which the PI led and helped establish. In addition, a digital library of the pathology slides will be generated for each participant and made publicly available. Finally, the BBC will work to develop novel methods for the assessment of RHI and cTBI-related injury to include axonal and white matter degeneration, gliosis, and inflammation. The specific aims also build upon the significant innovations of the PI and investigators with regard to RHI, cTBI, and CTE and focus on determining the pathological and clinical associations following brain impacts and injury. To accomplish these aims, the BBC will work in close collaboration with the Administration and Data Cores and Projects 1-3, as well as the associated ISMMS Alzheimer's Disease and Research Center Brain Bank and the BUADC. Overall, the BBC will provide a harmonized neuropathological workup and assessment in order to facilitate the storage and distribution of biospecimens, comprehensive diagnoses, digital library creation, and the development of novel quantitative neuropathological measures in order to best capture the chronic sequalae of RHI and TBI. Specimens and data collected by the BBC will be linked to RHI and TBI history determined in Project 1, harmonized clinical outcomes assessed in Project 2, and additional pathological and inflammatory measures determined in Project 3. The harmonized data will be used extensively across Projects 1-3 and made widely available for outside investigators.
脑库核心(BBC)的首要目标是开展和促进RHI和TBI的研究

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ann C. McKee其他文献

In vivo neurotoxicity of beta-amyloid [β(1–40)] and the β(25–35) fragment
β-淀粉样蛋白 [β(1–40)] 和 β(25–35) 片段的体内神经毒性
  • DOI:
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    N. Kowall;Ann C. McKee;B. Yankner;M. Beal
  • 通讯作者:
    M. Beal
VA’s National PTSD Brain Bank: a National Resource for Research
  • DOI:
    10.1007/s11920-017-0822-6
  • 发表时间:
    2017-08-25
  • 期刊:
  • 影响因子:
    6.700
  • 作者:
    Matthew J. Friedman;Bertrand R. Huber;Christopher B. Brady;Robert J. Ursano;David M. Benedek;Neil W. Kowall;Ann C. McKee
  • 通讯作者:
    Ann C. McKee
3.39 Identification of Neuropathological Substrates of Neuropsychiatric Symptoms in Adolescent and Young Adult Athletes Using Deep Learning
  • DOI:
    10.1016/j.jaac.2024.08.206
  • 发表时间:
    2024-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Daniel G. Koenigsberg;Justin Kauffman;Gabriel A. Marx;Andrew T. McKenzie;Timothy E. Richardson;Robina Afzal;Jon Cherry;Jesse Mez;Kurt Farrell;Ann C. McKee;John F. Crary
  • 通讯作者:
    John F. Crary
18F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy
  • DOI:
    10.1186/s13024-025-00808-1
  • 发表时间:
    2025-02-25
  • 期刊:
  • 影响因子:
    17.500
  • 作者:
    Michael L. Alosco;Jhony Mejía Pérez;Julia E. Culhane;Ranjani Shankar;Christopher J. Nowinski;Samantha Bureau;Nidhi Mundada;Karen Smith;Alinda Amuiri;Breton Asken;Jenna R. Groh;Annalise Miner;Erika Pettway;Sydney Mosaheb;Yorghos Tripodis;Charles Windon;Gustavo Mercier;Robert A. Stern;Lea T. Grinberg;David N. Soleimani-Meigooni;Bradley T. Christian;Tobey J. Betthauser;Thor D. Stein;Ann C. McKee;Chester A. Mathis;Eric E. Abrahamson;Milos D. Ikonomovic;Sterling C. Johnson;Jesse Mez;Renaud La Joie;Daniel Schonhaut;Gil D. Rabinovici
  • 通讯作者:
    Gil D. Rabinovici
Chronic Traumatic Encephalopathy: Where Are We and Where Are We Going?

Ann C. McKee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ann C. McKee', 18)}}的其他基金

Boston University Alzheimer's Disease Research Center
波士顿大学阿尔茨海默病研究中心
  • 批准号:
    10652548
  • 财政年份:
    2021
  • 资助金额:
    $ 66.5万
  • 项目类别:
Boston University Alzheimer's Disease Research Center
波士顿大学阿尔茨海默病研究中心
  • 批准号:
    10468304
  • 财政年份:
    2021
  • 资助金额:
    $ 66.5万
  • 项目类别:
Core D: Neuropathology Core
核心 D:神经病理学核心
  • 批准号:
    10652567
  • 财政年份:
    2021
  • 资助金额:
    $ 66.5万
  • 项目类别:
Core D: Neuropathology Core
核心 D:神经病理学核心
  • 批准号:
    10264291
  • 财政年份:
    2021
  • 资助金额:
    $ 66.5万
  • 项目类别:
Core D: Neuropathology Core
核心 D:神经病理学核心
  • 批准号:
    10468309
  • 财政年份:
    2021
  • 资助金额:
    $ 66.5万
  • 项目类别:
Neuropath Core
神经病核心
  • 批准号:
    10468283
  • 财政年份:
    2020
  • 资助金额:
    $ 66.5万
  • 项目类别:
CTBI:CBI Tauopathy in Mice and Human: Neurodegeneration after Repetitive Neurotrauma: Mechanisms and Biomarker Discovery
CTBI:小鼠和人类的 CBI Tau 蛋白病:重复性神经创伤后的神经变性:机制和生物标志物发现
  • 批准号:
    10436771
  • 财政年份:
    2020
  • 资助金额:
    $ 66.5万
  • 项目类别:
CTBI:CBI Tauopathy in Mice and Human: Neurodegeneration after Repetitive Neurotrauma: Mechanisms and Biomarker Discovery
CTBI:小鼠和人类的 CBI Tau 蛋白病:重复性神经创伤后的神经变性:机制和生物标志物发现
  • 批准号:
    10553627
  • 财政年份:
    2020
  • 资助金额:
    $ 66.5万
  • 项目类别:
Neuropath Core
神经病核心
  • 批准号:
    10047357
  • 财政年份:
    2020
  • 资助金额:
    $ 66.5万
  • 项目类别:
Neuropath Core
神经病核心
  • 批准号:
    10670334
  • 财政年份:
    2020
  • 资助金额:
    $ 66.5万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 66.5万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 66.5万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 66.5万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 66.5万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 66.5万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 66.5万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 66.5万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 66.5万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 66.5万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 66.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了